Subsequent Event (Details) (USD $) In Millions, unless otherwise specified	3 Months Ended
Mar. 31, 2012 Kai Pharmaceuticals [Member]	Apr. 25, 2012 Mustafa Nevzat Pharmaceuticals [Member]
Subsequent event (Textual) [Abstract]
Payment in cash to acquire company	$ 315
Total value of potential acquisition		$ 700
Minimum percentage of voting interest to be acquired		95.60%

Reflects the known or estimated financial effect of the event, or transaction that occurred between the balance sheet date and the date the financial statements are issued or available to be issued.

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Topic 855

-SubTopic 10

-Section 50

-Paragraph 2

-Name Accounting Standards Codification

-URI http://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Statement of Financial Accounting Standard (FAS)

-Number 165

-Paragraph 13

-Subparagraph b

-LegacyDoc This reference is SUPERSEDED by the Accounting Standards Codification effective for interim and annual periods ending after September 15, 2009. This reference is included to help users transition from the previous accounting hierarchy and will be removed from future versions of this taxonomy.

Name:	us-gaap_SubsequentEventAmount
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration